Does RIVAROXABAN Cause Coronary arterial stent insertion? 34 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Coronary arterial stent insertion have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.
34
Reports of Coronary arterial stent insertion with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
2
Deaths
10
Hospitalizations
How Dangerous Is Coronary arterial stent insertion From RIVAROXABAN?
Of the 34 reports, 2 (5.9%) resulted in death, 10 (29.4%) required hospitalization.
Is Coronary arterial stent insertion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Coronary arterial stent insertion?
ROSIGLITAZONE (1,698)
METFORMIN\ROSIGLITAZONE (245)
ADALIMUMAB (175)
EVOLOCUMAB (109)
RANOLAZINE (95)
RISANKIZUMAB-RZAA (94)
AVANDIA (68)
ETANERCEPT (67)
IBRUTINIB (54)
UPADACITINIB (52)
Which RIVAROXABAN Alternatives Have Lower Coronary arterial stent insertion Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM